PEP News
Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)
6 January, 2021 | ILEP Technical Commission
Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin A number of different problems have affected the supply of rifampicin and MDT to countries this year. The most … More Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)
A Prioritized Zero Leprosy Research Agenda
4 November, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy (GPZL) presented the prioritised Zero Leprosy Research Agenda at the WHO Global Consultation on Global Leprosy Strategy 2021 – 2030 last week. In 2018, the Research Agenda working group’s eight different sub-groups conducted a … More A Prioritized Zero Leprosy Research Agenda
Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
2 November, 2020 | Novartis International AG
Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
Project to End Child Leprosy Among Top 100 Proposals for MacArthur $100 Million Grant
26 February, 2020 | Global Partnership for Zero Leprosy
The John D. and Catherine T. MacArthur Foundation announced today that ‘End Child Leprosy by 2030: Break Transmission and Eliminate Stigma’ was one of the highest-scoring proposals, designated as the Top 100, in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical social challenges.
Workshop explores how to scale up PEP and advance research
11 November, 2019 | Global Partnership for Zero Leprosy
Leprosy Research Initiative (LRI), NLR, and the Global Partnership for Zero Leprosy (GPZL) co-hosted a workshop in Amsterdam in November 2019 to discuss issues related to post-exposure prophylaxis (PEP).
Guidelines for the diagnosis, treatment and prevention of leprosy
20 August, 2018 | World Health Organization
WHO’s Global Leprosy Programme has released the full Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. … More Guidelines for the diagnosis, treatment and prevention of leprosy